Hans Peter Schnebli

2.1k total citations
50 papers, 1.7k citations indexed

About

Hans Peter Schnebli is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hans Peter Schnebli has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Genetics and 11 papers in Oncology. Recurrent topics in Hans Peter Schnebli's work include Venomous Animal Envenomation and Studies (8 papers), Protease and Inhibitor Mechanisms (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Hans Peter Schnebli is often cited by papers focused on Venomous Animal Envenomation and Studies (8 papers), Protease and Inhibitor Mechanisms (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Hans Peter Schnebli collaborates with scholars based in Switzerland, Italy and United States. Hans Peter Schnebli's co-authors include L. Lee Bennett, Adolph Abrams, Th. Bächi, Donald L. Hill, Max M. Burger, H. Bittiger, A. E. Vatter, Michael N.G. James, Catherine A. McPhalen and Ralph K. Barclay and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Hans Peter Schnebli

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Peter Schnebli Switzerland 24 1.0k 228 147 146 135 50 1.7k
T. Hofmann Canada 24 1.1k 1.1× 233 1.0× 100 0.7× 136 0.9× 119 0.9× 50 1.8k
Walter C. Mahoney United States 26 1.6k 1.6× 155 0.7× 160 1.1× 151 1.0× 258 1.9× 48 2.5k
Annalisa Caputo Italy 16 866 0.8× 210 0.9× 249 1.7× 102 0.7× 88 0.7× 61 1.7k
J.-P. Mornon France 20 1.3k 1.2× 182 0.8× 194 1.3× 183 1.3× 135 1.0× 54 2.1k
John C. Voyta United States 18 1.4k 1.3× 120 0.5× 200 1.4× 241 1.7× 140 1.0× 37 2.3k
L B Chen United States 12 1.4k 1.4× 409 1.8× 163 1.1× 330 2.3× 154 1.1× 12 2.7k
Mikinori Kuwabara Japan 26 954 0.9× 205 0.9× 264 1.8× 252 1.7× 57 0.4× 128 2.2k
Marcos Mares-Guia Brazil 20 1.0k 1.0× 155 0.7× 67 0.5× 86 0.6× 129 1.0× 58 1.6k
Elmar Wächter Germany 31 2.4k 2.4× 381 1.7× 147 1.0× 261 1.8× 245 1.8× 80 3.0k
Roger A. Poorman United States 23 1.3k 1.3× 279 1.2× 225 1.5× 124 0.8× 174 1.3× 42 2.2k

Countries citing papers authored by Hans Peter Schnebli

Since Specialization
Citations

This map shows the geographic impact of Hans Peter Schnebli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Peter Schnebli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Peter Schnebli more than expected).

Fields of papers citing papers by Hans Peter Schnebli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Peter Schnebli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Peter Schnebli. The network helps show where Hans Peter Schnebli may publish in the future.

Co-authorship network of co-authors of Hans Peter Schnebli

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Peter Schnebli. A scholar is included among the top collaborators of Hans Peter Schnebli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Peter Schnebli. Hans Peter Schnebli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nick, Hanspeter, Pierre Acklin, Bernard Faller, et al.. (2002). ICL670A: Preclinical Profile. Advances in experimental medicine and biology. 509. 185–203. 59 indexed citations
2.
Cutruzzolà, Francesca, Donatella Barra, Gino Amiconi, et al.. (1994). Selective oxidation of methionyl residues in the human recombinant secretory leukocyte proteinase inhibitor. Effect on the inhibitor binding properties. Journal of Molecular Recognition. 7(1). 31–37. 4 indexed citations
3.
Frigerio, Francesco, Alessandro Coda, Luisa Pugliese, et al.. (1992). Crystal and molecular structure of the bovine α-chymotrypsin-eglin c complex at 2.0 Å resolution. Journal of Molecular Biology. 225(1). 107–123. 91 indexed citations
4.
Schnebli, Hans Peter. (1991). Recombinant Elastase Inhibitors for Therapy. Annals of the New York Academy of Sciences. 624(1). 212–218. 9 indexed citations
5.
6.
Schnebli, Hans Peter, et al.. (1991). Different Susceptibility of Elastase Inhibitors to Inactivation by Proteinases fromStaphylococcus aureusandPseudomonas aeruginosa. Biological Chemistry Hoppe-Seyler. 372(2). 963–970. 34 indexed citations
7.
Bolognesi, Martino, Luisa Pugliese, Alessandro Coda, et al.. (1990). X‐ray crystal structure of the bovine α‐chymotrypsin/eglin c complex at 2.6 Å resolution. Journal of Molecular Recognition. 3(4). 163–168. 10 indexed citations
8.
Gast, Alain, Wayne H. Anderson, A. Probst, et al.. (1990). Pharmacokinetics and Distribution of Recombinant Secretory Leukocyte Proteinase Inhibitor in Rats. American Review of Respiratory Disease. 141(4_pt_1). 889–894. 21 indexed citations
9.
Dean, Roger T. & Hans Peter Schnebli. (1989). Control of exogenous proteinases and their inhibitors at the macrophage cell surface. Biochimica et Biophysica Acta (BBA) - General Subjects. 992(2). 174–180. 5 indexed citations
10.
Pugliese, Luisa, Martino Bolognesi, Alessandro Coda, et al.. (1989). Preliminary crystallographic data on the complex of bovine α-chymotrypsin with the recombinant proteinase inhibitor eglin c from Hirudo medicinalis. Journal of Molecular Biology. 208(3). 511–513. 3 indexed citations
11.
Ascenzi, Paolo, Gino Amiconi, Enea Menegatti, et al.. (1988). Binding of the Recombinant Proteinase Inhibitor Eglin C from LeechHzrudo Medzcznalzsto Human Leukocyte Elastase, Bovine α-Chymotrypsin and Subtilisin Carlsberg: Thermodynamic Study. Journal of enzyme inhibition. 2(3). 167–172. 24 indexed citations
12.
Probst, A., et al.. (1988). Development of Eglin c as a Drug: Pharmacokinetics. Advances in experimental medicine and biology. 240. 83–88. 8 indexed citations
13.
Schnebli, Hans Peter, et al.. (1987). Interaction of Eglincwith Polymorphonuclear Cells: Evidence for Binding to the Cell Surface. Biological Chemistry Hoppe-Seyler. 368(1). 155–162. 8 indexed citations
14.
Schnebli, Hans Peter, Peter Christen, Marianne Jochum, R K Mallya, & Mark B. Pepys. (1984). Plasma Levels of Inhibitor-Bound Leukocytic Elastase in Rheumatoid Arthritis Patients. Advances in experimental medicine and biology. 167. 355–362. 13 indexed citations
15.
Nelles, Lynn P. & Hans Peter Schnebli. (1982). Subunit Structure of the Rat α-Macroglobulin Proteinase Inhibitors. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 363(2). 677–682. 27 indexed citations
16.
Howard, Guy A. & Hans Peter Schnebli. (1977). Eukaryote ribosomes possess a binding site for concanavalin A.. Proceedings of the National Academy of Sciences. 74(3). 818–821. 9 indexed citations
17.
Schnebli, Hans Peter, et al.. (1976). Concanavalin A as a tool. Wiley eBooks. 123 indexed citations
18.
Feigenson, Martin E., Marco Baggiolini, & Hans Peter Schnebli. (1976). Capping of concanavalin A- or ricin-binding sites does not influence phagocytosis in polymorphonuclear leukocytes. Cellular and Molecular Life Sciences. 32(10). 1264–1266. 2 indexed citations
19.
Schnebli, Hans Peter, et al.. (1974). Release from density-dependent inhibition of growth in the absence of cell locomotion. Journal of Cell Science. 16(1). 181–188. 17 indexed citations
20.
Bennett, L. Lee, et al.. (1966). Purine Ribonucleoside Kinase Activity and Resistance to Some Analogs of Adenosine. Molecular Pharmacology. 2(5). 432–443. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Hofmann Breakdown of academic impact, for papers by Walter C. Mahoney Breakdown of academic impact, for papers by Annalisa Caputo Breakdown of academic impact, for papers by J.-P. Mornon Breakdown of academic impact, for papers by John C. Voyta Breakdown of academic impact, for papers by L B Chen Breakdown of academic impact, for papers by Mikinori Kuwabara Breakdown of academic impact, for papers by Marcos Mares-Guia Breakdown of academic impact, for papers by Elmar Wächter Breakdown of academic impact, for papers by Roger A. Poorman
Rankless by CCL
2026